促销时间表 Cardiol Therapeutics Inc.
先进的时间表
简单图表
关于公司
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. 更多详情| Выручка | 7.9E-5 |
|---|---|
| EBITDA | -0.0134 |
| Число акций ао | 0.06446 млрд |
| P/S | 1350.96 |
| P/BV | 8.25 |
| Цена ао | 1.95 |
| EV/EBITDA | -8.51 |
| ISIN | CA14161Y2006 |
| Сайт | https://www.cardiolrx.com |
| Валюта | usd |
| IPO date | 2019-01-15 |
| Sector | Health Care |
| Industry | Biotechnology |
| Валюта отчета | cad |
| 每日价格变化: | +1.03% (1.95) |
|---|---|
| 每周价格变化: | -4.83% (2.07) |
| 每月价格变化: | +7.65% (1.83) |
| 3个月内价格变化: | +3.68% (1.9) |
| 六个月内的价格变化: | +5.35% (1.87) |
| 每年价格变化: | +145.94% (0.801) |
| 3年内价格变化: | -58.96% (4.8) |
| 5年内价格变化: | -38.38% (3.197) |
| 年初以来价格变化: | +134.52% (0.84) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| MMCAP International, Inc. SPC | 2953300 | 4.33 |
| AdvisorShares Investments, LLC | 1189978 | 1.75 |
| Tejara Capital Ltd | 1116676 | 1.64 |
| AXS Investments, LLC | 697651 | 1.02 |
| Lion Street Advisors, LLC | 192700 | 0.28 |
| Bank of Montreal/Can/ | 104479 | 0.15 |
| We Are One Seven, LLC | 100000 | 0.15 |
| Laird Norton Trust Company, LLC | 100000 | 0.15 |
| Cambridge Investment Research Advisors Inc. | 85201 | 0.12 |
| Credit Suisse Ag/ | 80000 | 0.12 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| AdvisorShares Pure Cannabis ETF | 6.51027 | 5.5762081784387 | 1.68573 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. David G. Elsley MBA | President, CEO & Director | 550.14k | |
| Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA | CFO, Corporate Secretary & Director | 216.79k | |
| Mr. Bernard Lim B.Sc. | Chief Operating Officer | 379.39k | |
| Dr. Andrew Warwick Hamer M.D. | Chief Medical Officer & Head of Research & Development | 549.01k | 1962 (62 年) |
| Trevor Burns | Investor Relations | N/A | |
| Mr. John A. Geddes BSCPT, MBA | Vice President of Corporate Development |
地址: Canada, Oakville, 2265 Upper Middle Road East - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.cardiolrx.com
网站: https://www.cardiolrx.com
